Back to RecallTracker
Health Canada Health products

Octagam 10% (Immune globulin intravenous, Human):Quality issue

Issued February 23, 2022
Issue
Elevated reporting rate of hypersensitivity reactions in affected lot.
Hazard description
Product quality
What to do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
Octagam 10% (Immune globulin intravenous, Human)
Reference
ID
RA-63944